External validation of Pentafecta in patients undergoing laparoscopic radical cystectomy: results from a high-volume center

BACKGROUND: To investigate whether Pentafecta is suitable for bladder cancer patients receiving laparoscopic radical cystectomy (LRC). METHODS: From November 2013 to December 2020, muscle invasive Bladder Cancer (MIBC) and non-muscle invasive Bladder Cancer (NMIBC) patients who received LRC and urin...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kai, Yang, Xiao, Zhuang, Juntao, Cai, Lingkai, Han, Jie, Yu, Hao, Zhou, Zijian, Lv, Jianchen, Feng, Dexiang, Yuan, Baorui, Wu, Qikai, Li, Pengchao, Cao, Qiang, Lu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939065/
https://www.ncbi.nlm.nih.gov/pubmed/35313884
http://dx.doi.org/10.1186/s12894-022-00987-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939065/
https://www.ncbi.nlm.nih.gov/pubmed/35313884
http://dx.doi.org/10.1186/s12894-022-00987-9

Ejemplares similares